A novel aptamer-based fluorescent sensor using Lettuce indicator, a light-up DNA aptamer that adopts a precise three-dimensional structure, which enables it to selectively bind and activate the otherwise non-fluorescent small-molecule fluorophore, generating a target-dependent fluorescent signal.
Abstract
DNA aptamers are widely used in the construction of fluorescent sensors, typically employing labelled fluorophores as signaling indicators. However, this covalent labeling approach suffers from several limitations, including complex and costly chemical modification, incompatibility with long aptamer sequences, and susceptibility to false-positive signals. To address these limitations, we constructed a novel aptamer-based fluorescent sensor using Lettuce indicator, a light-up DNA aptamer that adopts a precise three-dimensional structure, which enables it to selectively bind and activate the otherwise non-fluorescent small-molecule fluorophores. In our design, we destabilized Lettuce by fusing it with a target-binding aptamer via a transducer sequence. Upon target binding, structural rearrangement is triggered through the transducer, leading to the folding of Lettuce and restoration of its ability to activate the fluorophore, generating a target-dependent fluorescent signal. Through systematic optimization of the transducer and target-binding aptamer sequences, we created sensors for diverse targets, including small molecules, proteins, and metal ions. These sensors exhibit high signal-to-noise ratios, sensitivity and selectivity, and a wide dynamic range. As a proof-of-concept demonstration, a paper-based test strip for cost-effective and rapid detection of small molecule mycotoxins was developed. This versatile design provides a generalizable platform for the development of aptamer-based sensors, opening the way for future detection of diverse analytes.
Doxorubicin is an important chemotherapeutic agent, making its sensitive detection essential for therapeutic monitoring and food safety assessment. Although DNA aptamers exhibit high affinity and specificity toward doxorubicin, the absence of well-defined structural motifs often hampers the development of rapid, labe...
Zi-Han Gao, Jia-Min Wu, Shi-Jing Wang et al.· Arabian Journal of Chemistry· 0 citations
Lateral flow assays (LFAs) are widely used in point-of-care diagnostics due to their rapid readout, low cost, and operational simplicity; however, their limited sensitivity hinders the detection of low-abundance biomarkers. Existing signal amplification strategies often fail to precisely modulate signal intensity while...
Bao-Hong He, Xi-Wei Wang, Xiao-Lu Han et al.· Biosensors & bioelectronics· 0 citations
Cell-surface receptors are essential biomarkers and therapeutic targets, yet detecting them in native biological environments remains challenging. Turn-on, ligand-directed fluorescent probes have advanced the study of these receptors by enabling low-background imaging and the sensing of interactions with binding partne...
Since the advent of systematic evolution of ligands by exponential enrichment (SELEX), numerous protein-binding aptamers have been reported, yet their binding characterizations are often less developed than those of small-molecule aptamers, limiting mechanistic understanding and practical applications. Here, we establi...
Modulating aptamer-ligand interactions in response to pH is essential for developing nucleic acid sensors and molecular devices capable of functioning across diverse biological pH environments. Current approaches to engineer pH-responsive aptamers predominantly rely on appending pH-sensitive motifs to the termini of th...
Jagadeesh Sathiri, A. Krishna, Jothi Basu et al.· ACS Chemical Biology· 0 citations
RNA and DNA biomarkers serve as diagnostic molecules for detecting a specific disease by a variety of methods and technologies. A common approach is based on a fluorescence readout signal generated after hybridization to a target nucleic acid sequence. One such technology is termed Forced-Intercalation Peptide Nuclei...
Amer Fadila, Pinaki Chanda, Salam Maree et al.· Chemical & Biomedical
Im...· 0 citations
A new machine-learning framework aims to improve the success rate of computational protein design while moving away from results that reproduce sequences found in nature.